Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation

NCT01120366 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

233

Enrollment

NETWORK

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab plus methotrexate
DRUG: Tocilizumab

Sponsor

SURPRISE Study Group